1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Cardiovasculares

Enfermedades Cardiovasculares

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Senior R, Becher H, Monaghan M, Agati L, Zamorano J, Vanoverschelde JL, Nihoyannopoulos P, Edvardsen T, Lancellotti P, EACVI Scientific Documents Committee for 2014–16 and 2016–18, EACVI Scientific Documents Committee for 2014–16 and 2016–18.

    Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017.

    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING . 18(11): . Nº de citas: 101

    [doi:10.1093/ehjci/jex182]

  • Salido Tahoces L, Hernández Antolín RA, Zamorano Gómez JL.

    Aortic stenosis. Indications and results of percutaneous aortic valve implantation (TAVI).

    REVISTA CLINICA ESPANOLA . 217(8): 478-483.

    [doi:10.1016/j.rce.2017.05.001]

  • Chan J, Shiino K, Obonyo NG, Hanna J, Chamberlain R, Small A, Scalia IG, Scalia W, Yamada A, Hamilton-Craig CR, Scalia GM, Zamorano JL.

    Left Ventricular Global Strain Analysis by Two-Dimensional Speckle-Tracking Echocardiography: The Learning Curve.

    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY . 30(11): 1081-1090. Nº de citas: 49

    [doi:10.1016/j.echo.2017.06.010]

  • Quintanilla JG, Moreno J, Archondo T, Alfonso-Almazán JM, Lillo-Castellano JM, Usandizaga E, García-Torrent MJ, Rodríguez-Bobada C, González P, Borrego L, Cañadas-Godoy V, González-Ferrer JJ, Pérez-Castellano N, Pérez-Villacastín J, Filgueiras-Rama D.

    QRS duration reflects underlying changes in conduction velocity during increased intraventricular pressure and heart failure.

    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY . 130(Pt B): 394-403. Nº de citas: 6

    [doi:10.1016/j.pbiomolbio.2017.08.003]

  • Alonso Salinas GL, Sanmartin M, Pascual Izco M, Rincon LM, Pastor Pueyo P, Marco Del Castillo A, Garcia Guerrero A, Caravaca Perez P, Recio-Mayoral A, Camino A, Jimenez-Mena M, Zamorano JL.

    Frailty is an independent prognostic marker in elderly patients with myocardial infarction.

    CLINICAL CARDIOLOGY . 40(10): 925-931. Nº de citas: 31

    [doi:10.1002/clc.22749]

  • Hinojar R, Zamorano JL, Gonzalez Gómez A, Plaza Martin M, Esteban A, Rincón LM, Portugal JC, Jimenez Nácher JJ, Fernández-Golfín C.

    ESC sudden-death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast-enhanced CMR in intermediate-risk patients.

    CLINICAL CARDIOLOGY . 40(10): 853-860. Nº de citas: 9

    [doi:10.1002/clc.22735]

  • Habib G, Bucciarelli-Ducci C, Caforio ALP, Cardim N, Charron P, Cosyns B, Dehaene A, Derumeaux G, Donal E, Dweck MR, Edvardsen T, Erba PA, Ernande L, Gaemperli O, Galderisi M, Grapsa J, Jacquier A, Klingel K, Lancellotti P, Neglia D, Pepe A, Perrone-Filardi P, Petersen SE, Plein S, Popescu BA, Reant P, Sade LE, Salaun E, Slart RHJA, Tribouilloy C, Zamorano J, Reviewers: Victoria Delgado, Kristina Haugaa (EACVI Scientific Documents Committ.

    Multimodality Imaging in Restrictive Cardiomyopathies: An EACVI expert consensus document In collaboration with the Working Group on myocardial and pericardial diseases of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography.

    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING . 18(10): 1090-1121. Nº de citas: 58

    [doi:10.1093/ehjci/jex034]

  • Puntmann VO, Isted A, Hinojar R, Foote L, Carr-White G, Nagel E.

    T1 and T2 Mapping in Recognition of Early Cardiac Involvement in Systemic Sarcoidosis.

    Radiology . 285(1): 63-72. Nº de citas: 85

    [doi:10.1148/radiol.2017162732]

  • Barrios V, Escobar C, Prieto Valiente L, Lobos JM, Vargas-Ortega D, Polo J, Marin Montañés N.

    Blood pressure control in anticoagulated patients with hypertension and atrial fibrillation.

    Blood Pressure . 26(5): 279-283. Nº de citas: 3

    [doi:10.1080/08037051.2017.1313094]

  • Sanmartín-Fernández M, Marzal-Martín D.

    Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Clinical Practice: Focus on Rivaroxaban in Stroke Prevention in Patients With Atrial Fibrillation.

    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS . 23(7): 711-724. Nº de citas: 1

    [doi:10.1177/1076029616668404]

  • Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Muñoz D, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL.

    2017 ESC/EACTS Guidelines for the management of valvular heart disease.

    EUROPEAN HEART JOURNAL . 38(36): 2739-2791. Nº de citas: 3398

    [doi:10.1093/eurheartj/ehx391]

  • Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Neumann FJ, Tarantini G, Zamorano JL, Vahanian A.

    SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve.

    EUROPEAN HEART JOURNAL . 38(36): 2717-2726. Nº de citas: 84

    [doi:10.1093/eurheartj/ehx294]

  • Caforio ALP, Adler Y, Agostini C, Allanore Y, Anastasakis A, Arad M, Böhm M, Charron P, Elliott PM, Eriksson U, Felix SB, Garcia-Pavia P, Hachulla E, Heymans S, Imazio M, Klingel K, Marcolongo R, Matucci Cerinic M, Pantazis A, Plein S, Poli V, Rigopoulos A, Seferovic P, Shoenfeld Y, Zamorano JL, Linhart A.

    Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease.

    EUROPEAN HEART JOURNAL . 38(35): 2649-2662. Nº de citas: 89

    [doi:10.1093/eurheartj/ehx321]

  • Chambers JB, Prendergast B, Iung B, Rosenhek R, Zamorano JL, Piérard LA, Modine T, Falk V, Kappetein AP, Pibarot P, Sundt T, Baumgartner H, Bax JJ, Lancellotti P.

    Standards defining a 'Heart Valve Centre': ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint.

    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY . 52(3): 418-424. Nº de citas: 10

    [doi:10.1093/ejcts/ezx283]

  • Lenarczyk R, Potpara TS, Haugaa KH, Deharo JC, Hernandez-Madrid A, Del Carmen Exposito Pineda M, Kiliszek M, Dagres N.

    Approach to cardio-oncologic patients with special focus on patients with cardiac implantable electronic devices planned for radiotherapy: results of the European Heart Rhythm Association survey.

    EUROPACE . 19(9): 1579-1584. Nº de citas: 12

    [doi:10.1093/europace/eux195]

  • Lobos-Bejarano JM, Castellanos Rodríguez A, Barrios V, Escobar C, Polo-García J, Del Castillo-Rodríguez JC, Vargas-Ortega D, Lopez-Pineda A, Prieto-Valiente L, Lip GYH, PAULA Study Team.

    Influence of renal function on anticoagulation control in patients with non-valvular atrial fibrillation taking vitamin K antagonists.

    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE . 71(9): . Nº de citas: 6

    [doi:10.1111/ijcp.12974]

  • Moreno J, Franco E, Sánchez I.

    Macroreentrant atrial tachycardia around the native common atrioventricular valve in a surgically corrected complete atrioventricular septal defect.

    EUROPACE . 19(9): 1438-1438.

    [doi:10.1093/europace/euw410]

  • Monteagudo Ruiz JM, Fernández-Golfín C, Mesa D, González-Alujas T, Sitges M, Carrasco-Chinchilla F, Li CH, Grande-Trillo A, Martínez A, Matabuena J, Alonso-Rodríguez D, Aquila I, Zamorano JL.

    Prevalence of optimal valve morphology for MitraClip in patients with mitral regurgitation.

    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES . 34(8): 1122-1129.

    [doi:10.1111/echo.13592]